Search form


Press Releases

Axcan Announces Conference Call and Webcast for Fourth Quarter and Fiscal 2006 Results

Nov 21, 2006 - 04:08 ET

MONT-SAINT-HILAIRE, QUEBEC--(CCNMatthews - Nov. 21, 2006) - Axcan Pharma Inc. ("Axcan" or the "Company")(TSX:AXP)(NASDAQ:AXCA) today announced that it will report financial results for the fourth quarter and the fiscal year ended September 30, 2006, on Thursday, November 30, 2006, after market close.

Axcan will host a conference call at 8:30 A.M. ET, on Friday, December 1, 2006. Interested parties may also access the conference call by webcast at The webcast will be archived for 90 days.

The telephone numbers to access the conference call are (800) 814-4861 (Canada and United States) or (416) 644-3417 (international). A replay of the call will be available until December 8, 2006. The telephone numbers to access the replay are (416) 640-1917 passcode: 21209653#, or (877) 289-8525 passcode: 21209653# (toll free).

About Axcan Pharma

Axcan is a leading multinational specialty pharmaceutical company focused on gastroenterology. The company develops and markets a broad line of prescription products to treat a range of gastrointestinal diseases and disorders such as inflammatory bowel disease, irritable bowel syndrome, cholestatic liver diseases and complications related to pancreatic insufficiency. Axcan's products are marketed by its own specialized sales forces in North America and Europe. Its common shares are listed on the NASDAQ Global Market under the symbol "AXCA" and on the Toronto Stock Exchange under the symbol "AXP".

Axcan Pharma Inc.
Isabelle Adjahi
Director, Investor Relations
450-467-2600 ext. 2000